23 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
infringement lawsuit within 45 days of the NDA and patent holders’ receipt of a Paragraph IV certification in most cases automatically prevents FDA from … infringement lawsuit against Teva (Civil Action No. 1:22-cv-02019) to defend our intellectual property rights protecting Gimoti. After we initiated
8-K
EX-1.1
EVOK
Evoke Pharma Inc
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company, and the Company
8-K
EX-99.1
gysowqu2 w8b3
15 May 23
Evoke Pharma Reports First Quarter 2023 Financial Results
4:23pm
8-K
EX-1.1
m8o5s
14 Jan 21
Evoke Pharma Announces Proposed Public Offering of Common Stock
5:22pm
8-K
EX-10.1
1s2tf 8cho3q
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
10-K
7z1nkrb
25 Mar 14
Annual report
12:00am